000 | 01908 a2200565 4500 | ||
---|---|---|---|
005 | 20250517140641.0 | ||
264 | 0 | _c20171011 | |
008 | 201710s 0 0 eng d | ||
022 | _a1178-2005 | ||
024 | 7 |
_a10.2147/COPD.S120241 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPiitulainen, Eeva | |
245 | 0 | 0 |
_aHealth status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years. _h[electronic resource] |
260 |
_bInternational journal of chronic obstructive pulmonary disease _c2017 |
||
300 |
_a495-500 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBreath Tests |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aForced Expiratory Volume |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aHealth Status |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aLung _xphysiopathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aNeonatal Screening |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdiagnosis |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 | _aRegistries |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSmoking _xadverse effects |
650 | 0 | 4 | _aSmoking Cessation |
650 | 0 | 4 | _aSmoking Prevention |
650 | 0 | 4 | _aSpirometry |
650 | 0 | 4 | _aSurveys and Questionnaires |
650 | 0 | 4 | _aSweden |
650 | 0 | 4 | _aVital Capacity |
650 | 0 | 4 |
_aalpha 1-Antitrypsin _xgenetics |
650 | 0 | 4 |
_aalpha 1-Antitrypsin Deficiency _xcomplications |
700 | 1 | _aMostafavi, Behrouz | |
700 | 1 | _aTanash, Hanan A | |
773 | 0 |
_tInternational journal of chronic obstructive pulmonary disease _gvol. 12 _gp. 495-500 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/COPD.S120241 _zAvailable from publisher's website |
999 |
_c26883990 _d26883990 |